Clinical trial
The Effect of PROCRIT on Hemoglobin and Hematocrit and the Relationship to Postoperative Function, Vigor and Strength in Patients Undergoing Primary Total Joint Arthroplasty: A Randomized, Parallel Group, Open-Label Trial
NCT00401869 is registered in ClinicalTrials.gov with Ortho Biotech, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of PROCRIT on Hemoglobin and Hematocrit and the Relationship to Postoperative Function, Vigor and Strength in Patients Undergoing Primary Total Joint Arthroplasty: A Randomized, Parallel Group, Open-Label Trial
- Lead sponsor
- Ortho Biotech, Inc.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 1999
- Completion date
- December 31, 2001
- Enrollment
- 289 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.